Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Analysts Set New Price Targets
A number of research firms recently commented on ESTA. Cowen increased their target price on shares of Establishment Labs from $95.00 to $125.00 in a research report on Friday, April 22nd. The Goldman Sachs Group increased their target price on shares of Establishment Labs from $57.00 to $65.00 and gave the company a "neutral" rating in a research report on Tuesday, August 9th. Cowen increased their target price on shares of Establishment Labs from $95.00 to $125.00 in a research report on Friday, April 22nd. Finally, BTIG Research decreased their target price on shares of Establishment Labs from $105.00 to $90.00 and set a "buy" rating for the company in a research report on Friday, June 24th.
Establishment Labs Price Performance
Establishment Labs stock traded up $1.27 during mid-day trading on Friday, reaching $65.40. 110,221 shares of the company traded hands, compared to its average volume of 157,035. The company has a current ratio of 4.50, a quick ratio of 2.23 and a debt-to-equity ratio of 9.17. Establishment Labs has a fifty-two week low of $46.93 and a fifty-two week high of $93.80. The firm's fifty day moving average is $57.70 and its two-hundred day moving average is $60.42.